抗疟药物：对Toll样受体关上大门？ - Suppr

Suppr

超能文献

Antimalarial agents: closing the gate on Toll-like receptors?

作者信息

Lafyatis Robert, York Michael, Marshak-Rothstein Ann

出版信息

Arthritis Rheum. 2006 Oct;54(10):3068-70. doi: 10.1002/art.22157.

DOI:10.1002/art.22157

PMID:17009223

Abstract

摘要

相似文献

Antimalarial agents: closing the gate on Toll-like receptors?

Arthritis Rheum. 2006 Oct;54(10):3068-70. doi: 10.1002/art.22157.

Antimalarial agents and lupus.

Rheum Dis Clin North Am. 1994 Feb;20(1):243-63.

Do Toll-like receptors contribute to the pathogenesis of lupus?

J Rheumatol. 2007 Aug;34(8):1641-2.

Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.

J Rheumatol. 2008 Aug;35(8):1559-66. Epub 2008 Jun 15.

Effect of antimalarial agents on fasting lipid profile in systemic lupus erythematosus.

J Rheumatol. 2001 Jul;28(7):1742.

[Antimalarials in lupus erythematosus treatment].

Przegl Lek. 2002;59(3):179-82.

[Antimalarial drugs in contemporary dermatologic therapy].

Ann Acad Med Stetin. 2011;57(1):38-44.

New concepts in antimalarial use and mode of action in dermatology.

Dermatol Ther. 2007 Jul-Aug;20(4):160-74. doi: 10.1111/j.1529-8019.2007.00131.x.

Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling.

Nat Clin Pract Rheumatol. 2006 Sep;2(9):458-9. doi: 10.1038/ncprheum0292.

Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al.

Arthritis Rheum. 2008 Jan 15;59(1):153; author reply 153-4. doi: 10.1002/art.23257.

引用本文的文献

Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus.

Heliyon. 2024 Apr 27;10(9):e30393. doi: 10.1016/j.heliyon.2024.e30393. eCollection 2024 May 15.

Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?

Clin Exp Med. 2023 Dec;23(8):4141-4152. doi: 10.1007/s10238-023-01142-w. Epub 2023 Jul 22.

Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis.

Rheumatol Ther. 2023 Aug;10(4):861-874. doi: 10.1007/s40744-023-00561-1. Epub 2023 May 12.

Lupus panniculitis: a rare bilateral and symmetrical manifestation of cutaneous lupus erythematosus in an adolescent girl.

Dermatol Reports. 2022 Jul 6;15(1):9515. doi: 10.4081/dr.2022.9515. eCollection 2023 Mar 7.

The HIT Study-The Hydroxychloroquine Effect in the Treatment of Patients with Age-Related Macular Degeneration: A Randomized Controlled Trial.

Medicina (Kaunas). 2023 Mar 11;59(3):551. doi: 10.3390/medicina59030551.

How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice.

Intern Med J. 2023 Mar;53(3):311-317. doi: 10.1111/imj.15908. Epub 2022 Aug 25.

The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle.

BMC Health Serv Res. 2021 Sep 3;21(1):913. doi: 10.1186/s12913-021-06954-8.

Chronic Inhibition of Toll-Like Receptor 9 Ameliorates Pulmonary Hypertension in Rats.

J Am Heart Assoc. 2021 Apr 6;10(7):e019247. doi: 10.1161/JAHA.120.019247. Epub 2021 Mar 31.

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.

Ann Med. 2021 Dec;53(1):117-134. doi: 10.1080/07853890.2020.1839959.

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.

Front Immunol. 2020 Aug 28;11:2159. doi: 10.3389/fimmu.2020.02159. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验